Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N FELLER

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Leukemia|April 15, 2003
A flow cytometric method to detect apoptosis-related protein expression in minimal residual disease in acute myeloid leukemiaA van Stijn, A Kok, M A van der Pol, et al.
Leukemia|April 12, 2003
Multiparameter flow cytometric quantification of apoptosis-related protein expressionA van Stijn, A Kok, M A van der Pol, et al.
Leukemia|July 30, 2003
Minimal residual disease in acute myeloid leukemia is predicted by P-glycoprotein activity but not by multidrug resistance protein activity at diagnosisM A van der Pol, N Feller, G J Ossenkoppele, et al.
Leukemia|June 18, 2004
MRD parameters using immunophenotypic detection methods are highly reliable in predicting survival in acute myeloid leukaemiaN Feller, M A van der Pol, A van Stijn, et al.
Blood|June 1, 1996
Quality control of multidrug resistance assays in adult acute leukemia: correlation between assays for P-glycoprotein expression and activityH J Broxterman, P Sonneveld, N Feller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1995
Functional multidrug resistance phenotype associated with combined overexpression of Pgp/MDR1 and MRP together with 1-beta-D-arabinofuranosylcytosine sensitivity may predict clinical response in acute myeloid leukemiaG J Schuurhuis, H J Broxterman, G J Ossenkoppele, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 1997
Multiple cycles of high-dose doxorubicin and cyclophosphamide with G-CSF mobilized peripheral blood progenitor cell support in patients with metastatic breast cancerA H Honkoop, E van der Wall, N Feller, et al.
Blood Cancer Journal|August 6, 2013
Defining consensus leukemia-associated immunophenotypes for detection of minimal residual disease in acute myeloid leukemia in a multicenter settingN Feller, V H J van der Velden, R A Brooimans, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Leukemia|April 15, 2003
A flow cytometric method to detect apoptosis-related protein expression in minimal residual disease in acute myeloid leukemiaA van Stijn, A Kok, M A van der Pol, et al.
Leukemia|April 12, 2003
Multiparameter flow cytometric quantification of apoptosis-related protein expressionA van Stijn, A Kok, M A van der Pol, et al.
Leukemia|July 30, 2003
Minimal residual disease in acute myeloid leukemia is predicted by P-glycoprotein activity but not by multidrug resistance protein activity at diagnosisM A van der Pol, N Feller, G J Ossenkoppele, et al.
Leukemia|June 18, 2004
MRD parameters using immunophenotypic detection methods are highly reliable in predicting survival in acute myeloid leukaemiaN Feller, M A van der Pol, A van Stijn, et al.
Blood|June 1, 1996
Quality control of multidrug resistance assays in adult acute leukemia: correlation between assays for P-glycoprotein expression and activityH J Broxterman, P Sonneveld, N Feller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1995
Functional multidrug resistance phenotype associated with combined overexpression of Pgp/MDR1 and MRP together with 1-beta-D-arabinofuranosylcytosine sensitivity may predict clinical response in acute myeloid leukemiaG J Schuurhuis, H J Broxterman, G J Ossenkoppele, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 1997
Multiple cycles of high-dose doxorubicin and cyclophosphamide with G-CSF mobilized peripheral blood progenitor cell support in patients with metastatic breast cancerA H Honkoop, E van der Wall, N Feller, et al.
Blood Cancer Journal|August 6, 2013
Defining consensus leukemia-associated immunophenotypes for detection of minimal residual disease in acute myeloid leukemia in a multicenter settingN Feller, V H J van der Velden, R A Brooimans, et al.
Pageof 6